Gil Blum

Stock Analyst at Needham

(4.71)
# 162
Out of 4,460 analysts
254
Total ratings
60.56%
Success rate
24.71%
Average return
Main Sectors:
Top Industries:

23 Stocks

Taysha Gene Therapies
Jun 17, 2024
Reiterates: Buy
Price Target: $7
Current: $2.97
Upside: +135.69%
Autolus Therapeutics
Jun 17, 2024
Reiterates: Buy
Price Target: $9
Current: $3.90
Upside: +130.77%
Nurix Therapeutics
Jun 17, 2024
Reiterates: Buy
Price Target: $31
Current: $18.44
Upside: +68.11%
CRISPR Therapeutics AG
Jun 17, 2024
Reiterates: Buy
Price Target: $88
Current: $60.57
Upside: +45.29%
Shattuck Labs
Jun 14, 2024
Maintains: Buy
Price Target: $12$8
Current: $4.59
Upside: +74.29%
Mereo BioPharma Group
Jun 12, 2024
Maintains: Buy
Price Target: $6$7
Current: $3.98
Upside: +75.88%
Geron
Jun 7, 2024
Maintains: Buy
Price Target: $5$6
Current: $4.49
Upside: +33.63%
Immunocore Holdings
Jun 3, 2024
Reiterates: Buy
Price Target: $81
Current: $35.94
Upside: +125.38%
Celcuity
May 31, 2024
Maintains: Buy
Price Target: $24$23
Current: $14.89
Upside: +54.47%
G1 Therapeutics
May 28, 2024
Reiterates: Buy
Price Target: $12
Current: $2.56
Upside: +368.75%
Sarepta Therapeutics
May 20, 2024
Reiterates: Buy
Price Target: $166
Current: $117.52
Upside: +41.25%
Generation Bio Co.
May 14, 2024
Reiterates: Buy
Price Target: $10
Current: $2.70
Upside: +270.37%
Nkarta
May 13, 2024
Maintains: Buy
Price Target: $15$13
Current: $5.27
Upside: +146.68%
TScan Therapeutics
May 13, 2024
Reiterates: Buy
Price Target: $11
Current: $6.94
Upside: +58.50%
Arcellx
May 10, 2024
Reiterates: Buy
Price Target: $81
Current: $53.81
Upside: +50.53%
Amicus Therapeutics
May 10, 2024
Reiterates: Hold
Price Target: n/a
Current: $9.77
Upside: -
Recursion Pharmaceuticals
May 10, 2024
Reiterates: Buy
Price Target: $17
Current: $9.70
Upside: +75.26%
Cartesian Therapeutics
May 8, 2024
Reiterates: Buy
Price Target: $42
Current: $21.76
Upside: +93.01%
Rocket Pharmaceuticals
May 7, 2024
Reiterates: Buy
Price Target: $53
Current: $20.68
Upside: +156.29%
NextCure
May 3, 2024
Reiterates: Buy
Price Target: $4
Current: $1.32
Upside: +203.03%
I-Mab
Apr 12, 2024
Reiterates: Buy
Price Target: $6
Current: $1.77
Upside: +238.98%
Fate Therapeutics
Apr 11, 2024
Reiterates: Hold
Price Target: n/a
Current: $3.41
Upside: -
AVROBIO
Mar 24, 2023
Reiterates: Buy
Price Target: $6
Current: $1.42
Upside: +322.54%